Publicaciones (429) Publicaciones en las que ha participado algún/a investigador/a

2010

  1. 18F-FDG PET bio-metabolic monitoring of neoadjuvant therapy effects in rectal cancer: Focus on nodal disease characteristics

    Radiotherapy and Oncology, Vol. 97, Núm. 2, pp. 212-216

  2. A 3-year Mediterranean-style dietary intervention may modulate the association between adiponectin gene variants and body weight change

    European Journal of Nutrition, Vol. 49, Núm. 5, pp. 311-319

  3. A 3-year intervention with a Mediterranean diet modified the association between the rs9939609 gene variant in FTO and body weight changes

    International Journal of Obesity, Vol. 34, Núm. 2, pp. 266-272

  4. A Prospective Evaluation of Cerebral Infarction following Transcervical Carotid Stenting with Carotid Flow Reversal

    European Journal of Vascular and Endovascular Surgery, Vol. 39, Núm. 6, pp. 661-666

  5. A direct projection from the subthalamic nucleus to the ventral thalamus in monkeys

    Neurobiology of Disease, Vol. 39, Núm. 3, pp. 381-392

  6. A finite element inverse analysis to assess functional improvement during the fracture healing process

    Journal of Biomechanics, Vol. 43, Núm. 3, pp. 557-562

  7. A mediterranean diet rich in virgin olive oil may reverse the effects of the-174g/c il6 gene variant on 3-year body weight change

    Molecular Nutrition and Food Research, Vol. 54, Núm. SUPPL. 1

  8. A new mutation in the hMSH2 gene in a Spanish Lynch syndrome family

    Clinical and Translational Oncology, Vol. 12, Núm. 12, pp. 849-851

  9. A novel BRCA2 mutation that segregates with breast and prostate cancer in a Spanish family

    Breast Cancer Research and Treatment, Vol. 121, Núm. 1, pp. 219-220

  10. A novel system for the production of high levels of functional human therapeutic proteins in stable cells with a Semliki Forest virus noncytopathic vector

    New Biotechnology, Vol. 27, Núm. 2, pp. 138-148

  11. A peptide inhibitor of FOXP3 impairs regulatory T cell activity and improves vaccine efficacy in mice

    Journal of Immunology, Vol. 185, Núm. 9, pp. 5150-5159

  12. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer

    International Journal of Gynecological Cancer, Vol. 20, Núm. 1, pp. 133-140

  13. A phase i clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma

    Cancer Gene Therapy, Vol. 17, Núm. 12, pp. 837-843

  14. A quantitative analysis of genomic instability in lymphoid and plasma cell neoplasms based on the PIG-A gene

    Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 686, Núm. 1-2, pp. 1-8

  15. A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, Núm. 39, pp. 16982-16987

  16. ABC transporters as molecular effectors of pancreatic oncogenic pathways: The hedgehog-GLI model

    Journal of Gastrointestinal Cancer, Vol. 41, Núm. 3, pp. 153-158

  17. Abordaje radiológico: Diagnóstico, estadiaje y drenaje de la vía biliar

    Gastroenterologia y Hepatologia Continuada, Vol. 9, Núm. 3, pp. 106-112

  18. Actitud del neurólogo español frente a la migraña: Resultados del proyecto CIEN-mig (I)

    Revista de Neurologia, Vol. 50, Núm. 10, pp. 577-583

  19. Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: A phase 2 study (SOGUG-02-06)

    The Lancet Oncology, Vol. 11, Núm. 4, pp. 350-357

  20. Actualización en malformaciones venosas

    Anales del sistema sanitario de Navarra, Vol. 33, Núm. 3, pp. 297-308